Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib.

Costa DB, Nguyen KS, Cho BC, Sequist LV, Jackman DM, Riely GJ, Yeap BY, Halmos B, Kim JH, Jänne PA, Huberman MS, Pao W, Tenen DG, Kobayashi S
Clin Cancer Res. 2008 14 (21): 7060-7

PMID: 18981003 · PMCID: PMC2596582 · DOI:10.1158/1078-0432.CCR-08-1455

MeSH Terms (18)

Adenocarcinoma Adult Aged Aged, 80 and over Antineoplastic Agents Carcinoma, Non-Small-Cell Lung Drug Resistance, Neoplasm ErbB Receptors Erlotinib Hydrochloride Female Gefitinib Humans Lung Neoplasms Male Middle Aged Mutation Protein Kinase Inhibitors Quinazolines

Connections (1)

This publication is referenced by other Labnodes entities: